Cerebral Aspergillosis
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Imagine PharmaPA - Pittsburgh
1 programEuropean Study of Cerebral Aspergillosis Treated With IsavuconazoleN/ASmall Molecule1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Imagine PharmaEuropean Study of Cerebral Aspergillosis Treated With Isavuconazole
Clinical Trials (1)
Total enrollment: 41 patients across 1 trials
European Study of Cerebral Aspergillosis Treated With Isavuconazole
Start: Aug 2021Est. completion: Mar 202341 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.